Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling
Open Access
- 8 December 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (23)
Abstract
Nonalcoholic steatohepatitis (NASH) is closely related to liver fibrosis. The role of coiled-coil-helix-coiled-coil-helix domain-containing 2 (CHCHD2) in NASH remains unknown. CHCHD2’s functions as a transcription factor have received much less attention than those in mitochondria. Herein, we systematically characterized the role of CHCHD2 as a transcription factor by chromatin immunoprecipitation sequencing and found its target genes were enriched in nonalcoholic fatty liver disease (NAFLD). Overall, CHCHD2 expression was found to be increased in the livers of patients with NAFLD and those of NASH mice. In line with these findings, CHCHD2 deficiency ameliorated NASH- and thioacetamide-induced liver fibrosis, whereas hepatocyte-specific CHCHD2 overexpression promoted liver fibrosis in NASH mice via Notch signaling. Specifically, CHCHD2-overexpressing hepatocytes activated hepatic stellate cells by upregulating osteopontin levels, a downstream mediator of Notch signals. Moreover, Notch inhibition attenuated CHCHD2 overexpression–induced liver fibrosis in vivo and in vitro. Then we found lipopolysaccharide-induced CHCHD2 expression in hepatocytes was reverted by verteporfin, an inhibitor that disrupts the interaction between Yes-associated protein (YAP) and transcriptional enhanced associate domains (TEADs). In addition, CHCHD2 levels were positively correlated with those of TEAD1 in human samples. In conclusion, CHCHD2 is upregulated via YAP/TAZ-TEAD in NASH livers and consequently promotes liver fibrosis by activating the Notch pathway and enhancing osteopontin production.Keywords
Funding Information
- National Key Research and Development Program of China (2019YFA0802003)
- National Natural Science Foundation of China (82000555)
- National Natural Science Foundation of China (81822006)
- National Natural Science Foundation of China (81500439)
- National Natural Science Foundation of China (82170635)
- National Natural Science Foundation of China (82170591)
- Natural Science Foundation of Tianjin Municipality (20JCYBJC01120)
This publication has 44 references indexed in Scilit:
- MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolismMitochondrion, 2015
- CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activationCell Death & Differentiation, 2014
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, ChinaJournal of Gastroenterology and Hepatology, 2013
- Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2Nucleic Acids Research, 2013
- Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic ratsHepatology, 2012
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent mannerNature Medicine, 2011
- Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in MiceGastroenterology, 2011
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005